Eldad Zacksenhaus

5.1k total citations
105 papers, 3.3k citations indexed

About

Eldad Zacksenhaus is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Eldad Zacksenhaus has authored 105 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 51 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Eldad Zacksenhaus's work include Cancer-related Molecular Pathways (32 papers), Ubiquitin and proteasome pathways (13 papers) and Ocular Oncology and Treatments (11 papers). Eldad Zacksenhaus is often cited by papers focused on Cancer-related Molecular Pathways (32 papers), Ubiquitin and proteasome pathways (13 papers) and Ocular Oncology and Treatments (11 papers). Eldad Zacksenhaus collaborates with scholars based in Canada, China and United States. Eldad Zacksenhaus's co-authors include Zhe Jiang, Jeff C. Liu, Brenda L. Gallie, Robert A. Phillips, Sean E. Egan, Yaacov Ben‐David, Tao Deng, Rod Bremner, Dong‐Yu Wang and Zhiqiang Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Eldad Zacksenhaus

103 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eldad Zacksenhaus Canada 30 2.2k 1.5k 718 310 300 105 3.3k
Benilde Jiménez Spain 28 2.2k 1.0× 568 0.4× 841 1.2× 191 0.6× 215 0.7× 49 3.1k
Pierre de la Grange France 34 2.2k 1.0× 462 0.3× 630 0.9× 163 0.5× 273 0.9× 93 3.2k
Bernd Hinzmann Germany 24 1.7k 0.8× 808 0.5× 958 1.3× 174 0.6× 417 1.4× 47 3.0k
Elizabeth E. Reczek United States 9 2.1k 0.9× 1.2k 0.8× 513 0.7× 304 1.0× 197 0.7× 10 3.2k
Y.F. Ramos Netherlands 25 1.9k 0.9× 1.4k 0.9× 661 0.9× 85 0.3× 195 0.7× 84 3.2k
Naohiko Ikegaki United States 35 2.6k 1.1× 765 0.5× 854 1.2× 183 0.6× 314 1.0× 91 3.8k
John Easton United States 32 2.3k 1.0× 675 0.4× 678 0.9× 225 0.7× 295 1.0× 84 3.5k
Alain Eychène France 32 2.2k 1.0× 798 0.5× 333 0.5× 132 0.4× 246 0.8× 55 3.0k
Judy M. Coulson United Kingdom 26 1.8k 0.8× 581 0.4× 280 0.4× 215 0.7× 293 1.0× 66 2.4k

Countries citing papers authored by Eldad Zacksenhaus

Since Specialization
Citations

This map shows the geographic impact of Eldad Zacksenhaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eldad Zacksenhaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eldad Zacksenhaus more than expected).

Fields of papers citing papers by Eldad Zacksenhaus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eldad Zacksenhaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eldad Zacksenhaus. The network helps show where Eldad Zacksenhaus may publish in the future.

Co-authorship network of co-authors of Eldad Zacksenhaus

This figure shows the co-authorship network connecting the top 25 collaborators of Eldad Zacksenhaus. A scholar is included among the top collaborators of Eldad Zacksenhaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eldad Zacksenhaus. Eldad Zacksenhaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chunlin, Wuling Liu, Anling Hu, et al.. (2024). An intricate regulatory circuit between FLI1 and GATA1/GATA2/LDB1/ERG dictates erythroid vs. megakaryocytic differentiation. Molecular Medicine Reports. 29(6). 4 indexed citations
2.
Tang, Yaoliang, Chunlin Wang, Wuling Liu, et al.. (2024). The Astragalus Membranaceus Herb Attenuates Leukemia by Inhibiting the FLI1 Oncogene and Enhancing Anti-Tumor Immunity. International Journal of Molecular Sciences. 25(24). 13426–13426.
3.
Gao, Jian, Chunlin Wang, Wuling Liu, et al.. (2023). FLI1 Regulates Histamine Decarboxylase Expression to Control Inflammation Signaling and Leukemia Progression. Journal of Inflammation Research. Volume 16. 2007–2020. 5 indexed citations
4.
Shrestha, Mariusz, Dong‐Yu Wang, Yaacov Ben‐David, & Eldad Zacksenhaus. (2023). CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer. Oncogenesis. 12(1). 29–29. 12 indexed citations
5.
Ehli, Erik A., Christel M. Davis, Philip E.D. Chung, et al.. (2023). A temporal in vivo catalog of chromatin accessibility and expression profiles in pineoblastoma reveals a prevalent role for repressor elements. Genome Research. 33(2). 269–282. 2 indexed citations
6.
Hu, Anling, Jian Gao, Babu Gajendran, et al.. (2022). UM171 cooperates with PIM1 inhibitors to restrict HSC expansion markers and suppress leukemia progression. Cell Death Discovery. 8(1). 448–448. 4 indexed citations
7.
Chen, Beiling, Chunlin Wang, Xiao Xiao, et al.. (2022). FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L/R and other glycolytic genes. Medical Oncology. 40(2). 69–69. 4 indexed citations
8.
Liu, Wuling, Babu Gajendran, Klarke M. Sample, et al.. (2022). A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer. Cancer Gene Therapy. 29(11). 1590–1599. 2 indexed citations
9.
Ben‐David, Yaacov, Babu Gajendran, Klarke M. Sample, & Eldad Zacksenhaus. (2022). Current insights into the role of Fli-1 in hematopoiesis and malignant transformation. Cellular and Molecular Life Sciences. 79(3). 163–163. 20 indexed citations
10.
Gajendran, Babu, Wuling Liu, Chunlin Wang, et al.. (2020). A C21-steroidal derivative suppresses T-cell lymphoma in mice by inhibiting SIRT3 via SAP18-SIN3. Communications Biology. 3(1). 732–732. 10 indexed citations
11.
Wang, Dong‐Yu, Zhe Jiang, Yaacov Ben‐David, James R. Woodgett, & Eldad Zacksenhaus. (2019). Molecular stratification within triple-negative breast cancer subtypes. Scientific Reports. 9(1). 19107–19107. 96 indexed citations
12.
Liu, Jeff C., YoungJun Ju, Giovanna Pellecchia, et al.. (2017). microRNA-143/145 loss induces Ras signaling to promote aggressive Pten-deficient basal-like breast cancer. JCI Insight. 2(15). 20 indexed citations
13.
Adams, Jessica R., Jeff C. Liu, Amanda J. Loch, et al.. (2015). Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer Patients. Cancer Research. 75(22). 4960–4972. 48 indexed citations
14.
Deng, Tao, Jeff C. Liu, Philip E.D. Chung, et al.. (2014). shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer. Cancer Research. 74(7). 2119–2130. 29 indexed citations
15.
Liu, Guodong, Yanmei Li, Jeff C. Liu, et al.. (2013). mda- 7/IL-24 Expression Inhibits Breast Cancer through Upregulation of Growth Arrest-Specific Gene 3 ( gas3 ) and Disruption of β1 Integrin Function. Molecular Cancer Research. 11(6). 593–603. 14 indexed citations
16.
Liu, Jeff C., Véronique Voisin, Gary D. Bader, et al.. (2012). Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2 + :ERα − breast cancer. Proceedings of the National Academy of Sciences. 109(15). 5832–5837. 65 indexed citations
17.
Adams, Jessica R., Keli Xu, Jeff C. Liu, et al.. (2011). Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation. Cancer Research. 71(7). 2706–2717. 106 indexed citations
18.
Deng, Tao, Jeff C. Liu, Kathleen I. Pritchard, Andrea Eisen, & Eldad Zacksenhaus. (2008). Preferential Killing of Breast Tumor Initiating Cells by N,N -Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene. Clinical Cancer Research. 15(1). 119–130. 19 indexed citations
19.
Liu, Jeff C., Tao Deng, Rajwinder Lehal, Jinny Kim, & Eldad Zacksenhaus. (2007). Identification of Tumorsphere- and Tumor-Initiating Cells in HER2/Neu-Induced Mammary Tumors. Cancer Research. 67(18). 8671–8681. 133 indexed citations
20.
Ho, Andrew Tri Van, et al.. (2004). Coupling of caspase‐9 to Apaf1 in response to loss of pRb or cytotoxic drugs is cell‐type‐specific. The EMBO Journal. 23(2). 460–472. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benilde Jiménez Breakdown of academic impact, for papers by Pierre de la Grange Breakdown of academic impact, for papers by Bernd Hinzmann Breakdown of academic impact, for papers by Elizabeth E. Reczek Breakdown of academic impact, for papers by Y.F. Ramos Breakdown of academic impact, for papers by Naohiko Ikegaki Breakdown of academic impact, for papers by John Easton Breakdown of academic impact, for papers by Alain Eychène Breakdown of academic impact, for papers by Judy M. Coulson
Rankless by CCL
2026